Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study
about
Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental ArthritisDrugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.Low level of physical activity in women with rheumatoid arthritis is associated with cardiovascular risk factors but not with body fat mass--a cross sectional study.Total cholesterol and LDL levels decrease before rheumatoid arthritis.Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular diseaseSignificant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis.Effects of phylloquinone supplementation on lipid profile in women with rheumatoid arthritis: a double blind placebo controlled studyHyperlipidemia in rheumatoid arthritis patients in Saudi Arabia. Correlation with C-reactive protein levels and disease activity.Patients with early rheumatoid arthritis exhibit elevated autoantibody titers against mildly oxidized low-density lipoprotein and exhibit decreased activity of the lipoprotein-associated phospholipase A2.Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid ArthritisRisk factors for coronary heart disease in connective tissue diseasesDyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapyModulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis.Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis.High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study.Insulin resistance and levels of adipokines in patients with untreated early rheumatoid arthritisMetabolic syndrome in rheumatoid arthritisAtherogenic lipid profiles and its management in patients with rheumatoid arthritis.The effect of IL6-174C/G polymorphism on postprandial triglyceride metabolism in the GOLDN studyboxs.Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study.Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.Rheumatoid arthritis and cardiovascular disease: an update on treatment issues.Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisManagement of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.Psoriasis comorbidities.Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study.Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional studyImpact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based studySerum lipid changes and insulin resistance in familial Mediterranean fever.Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study.Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the 'age of remission'?IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis.Rheumatoid arthritis and cardiovascular disease
P2860
Q28552434-047E497B-624C-4CAD-936D-014AD11865DAQ33633643-44868FC0-DD31-41AB-B7B6-2B7A1393F6FBQ33793453-469B2CD3-8933-4843-9D0B-AC75A11C4E7AQ33931317-9AF95559-D6F0-47D2-AFD5-C764C0774924Q34614038-AE79F33D-D886-4A77-9EB1-D391F5305D0DQ34684331-CE378F84-939F-446D-AA60-2FE611659287Q35257568-EC0A5C3A-6D6E-40B7-A87C-02EB9C37DBD6Q35308212-ECDDC794-22E8-4E92-ABC7-0921780188CBQ35681167-FE0A262B-4C4C-46E1-BC3D-EDC83632572FQ35769101-78796E48-7C49-42C6-8DC5-DF556FCD5F79Q35891702-309E7014-3E09-488F-A4CB-3944B6ED50F3Q36056947-CED5E849-23AA-4295-A941-D43CC3BA87BFQ36113215-F7BDBC59-0DA3-44EE-83F8-EF428B3D447EQ36204149-8FA8EA30-7F0E-49B0-99AE-0D7B269E9C35Q36241707-CDC38E8A-6492-471A-A6D9-F4C3B3F8CDD5Q36245981-BE60032F-7FB8-4B8E-B0DF-CEB0C032A9D8Q36456346-CF96AD42-6D20-49A3-94F9-97B1EAE6E3B7Q36568868-2153757D-6C56-477D-9EBA-4080FCF4D77BQ36596894-95059D89-3B3A-463E-B56E-276C531C7014Q36745032-277922DC-041C-44F2-A1B6-FD93C9F4B2CCQ36757006-0758121C-2DB6-4C8D-AE72-7267CF1855C7Q36757060-21E57235-2862-4C5C-A237-50EE467B2E11Q36802963-F2299C03-83F0-4868-9D79-C6B8DC656B2EQ36812587-7FDC893A-74A3-4FBA-9DE8-A45C0DEBBB79Q36951050-CF48654B-204F-4E2A-99A8-8E1C5D40EE74Q36955395-560EB664-C849-4BC4-BDC5-C30C84AA47A1Q37058791-562BBC23-4FA5-4308-9259-2FDBC6160E4BQ37084274-2D758216-0E49-47A7-B30A-65564FDB903AQ37129611-0537C971-9C74-45BA-8057-8B3B97A3F5F6Q37206912-4E33417E-942E-4CCD-BB14-83BC220F8F63Q37209902-783564D6-6802-4819-B0DC-4D684E5F593FQ37296397-98759A3E-DED5-4E71-929B-E57EE115D3F8Q37430645-63F36F03-D5F1-4C91-B94A-A04571F7D0F7Q37479238-4B82102A-01E6-4EDD-AE22-EFD1207A4BDDQ37588725-BF6A832B-D70A-4846-ABF6-36368BED072BQ37612713-CF969B6C-4E53-45E0-BE71-85742BEAF775Q37640953-65A00656-AC28-4311-99CA-EE9ABBD8786FQ37651150-95F79303-7153-4993-BA5B-018660088326Q37817050-A15E601B-410B-48F0-87F1-E2ECB33F2446Q38149252-154CFF7A-C033-4E18-AFC5-D997E0BB3F83
P2860
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Atherogenic lipid profile is a ...... prospective, controlled study
@ast
Atherogenic lipid profile is a ...... prospective, controlled study
@en
Atherogenic lipid profile is a ...... prospective, controlled study
@nl
type
label
Atherogenic lipid profile is a ...... prospective, controlled study
@ast
Atherogenic lipid profile is a ...... prospective, controlled study
@en
Atherogenic lipid profile is a ...... prospective, controlled study
@nl
prefLabel
Atherogenic lipid profile is a ...... prospective, controlled study
@ast
Atherogenic lipid profile is a ...... prospective, controlled study
@en
Atherogenic lipid profile is a ...... prospective, controlled study
@nl
P2093
P2860
P356
P1476
Atherogenic lipid profile is a ...... prospective, controlled study
@en
P2093
Alexandros A Drosos
Alexandros D Tselepis
Athanasios N Georgiadis
Christina Kostara
Eleni C Papavasiliou
Evangelia S Lourida
Yannis Alamanos
P2860
P2888
P356
10.1186/AR1952
P577
2006-04-28T00:00:00Z
P5875
P6179
1048962136